PRME
Prime Medicine, Inc.
$3.87
-0.02 (-0.51%)
At close · Jul 2
Market Cap
$698.99M
Shares
180,617,451
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-08 | 2026-06-05 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2025-12-31 | |
| 8-K | 2026-04-16 | 2026-04-07 | |
| 8-K | 2026-03-03 | — | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-07 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-09-08 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-07 | — | |
| 8-K | 2025-08-05 | 2025-08-01 | |
| 8-K | 2025-07-31 | 2025-07-30 | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-07-15 | 2025-07-14 | |
| DEF 14A | 2025-07-14 | 2025-08-01 | |
| 8-K | 2025-06-05 | 2025-06-04 | |
| 8-K | 2025-05-19 | 2025-05-16 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-22 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-02-28 | — | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-24 | — | |
| 8-K | 2024-09-30 | 2024-09-28 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-05-21 | 2024-05-17 | |
| 8-K | 2024-05-10 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-12 | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-03-01 | — | |
| 8-K | 2024-02-16 | 2024-02-14 | |
| 8-K | 2024-02-14 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 10-Q | 2023-11-03 | 2023-09-30 | |
| 8-K | 2023-11-03 | — | |
| 8-K | 2023-08-07 | — |
Showing 1–50 of 63 filings